131 related articles for article (PubMed ID: 3207084)
1. ABO blood groups and their relationship to transitional cell carcinoma of the urinary bladder in 30 Jordanian patients.
Murshidi MS
Acta Urol Belg; 1988; 56(4):517-22. PubMed ID: 3207084
[No Abstract] [Full Text] [Related]
2. Blood group H antigen in transitional carcinoma of the urinary bladder.
Tichý M; Tichá V; Jansa P; Student V; Vanák J
Acta Univ Palacki Olomuc Fac Med; 1991; 130():157-62. PubMed ID: 1838863
[TBL] [Abstract][Full Text] [Related]
3. Relationship of blood groups and transitional cell carcinoma of the bladder.
Kirkali Z; Eryigit M
Int Urol Nephrol; 1993; 25(3):255-7. PubMed ID: 8225826
[TBL] [Abstract][Full Text] [Related]
4. Deletion of ABH blood group isoantigen and prognosis in patients with transitional cell bladder carcinoma.
Malmström PU; Busch C; Norlen BJ
Scand J Urol Nephrol Suppl; 1988; 110():205-11. PubMed ID: 3187409
[No Abstract] [Full Text] [Related]
5. Pathologist's role in bladder cancer.
Farrow GM
Semin Oncol; 1979 Jun; 6(2):198-206. PubMed ID: 482961
[No Abstract] [Full Text] [Related]
6. Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion.
Esrig D; Freeman JA; Elmajian DA; Stein JP; Chen SC; Groshen S; Simoneau A; Skinner EC; Lieskovsky G; Boyd SD; Cote RJ; Skinner DG
J Urol; 1996 Sep; 156(3):1071-6. PubMed ID: 8709310
[TBL] [Abstract][Full Text] [Related]
7. Small cell carcinoma of the urinary bladder. A clinicopathologic analysis of 64 patients.
Montie JE
J Urol; 2005 Jun; 173(6):1920-1. PubMed ID: 15879778
[No Abstract] [Full Text] [Related]
8. Impact of ABO blood type on outcomes in patients with primary nonmuscle invasive bladder cancer.
Klatte T; Xylinas E; Rieken M; Kluth LA; Rouprêt M; Pycha A; Fajkovic H; Seitz C; Karakiewicz PI; Lotan Y; Babjuk M; de Martino M; Scherr DS; Shariat SF
J Urol; 2014 May; 191(5):1238-43. PubMed ID: 24333243
[TBL] [Abstract][Full Text] [Related]
9. CA19.9 and CEA in transitional cell carcinoma of the bladder: serological and immunohistochemical findings.
Hegele A; Mecklenburg V; Varga Z; Olbert P; Hofmann R; Barth P
Anticancer Res; 2010 Dec; 30(12):5195-200. PubMed ID: 21187512
[TBL] [Abstract][Full Text] [Related]
10. [Expression of A,B and H blood group antigens in urothelial carcinoma of the urinary bladder].
Tichý M; Tichá V; Jansa P; Student V; Vanák J
Cesk Patol; 1991 Mar; 27(1-2):13-9. PubMed ID: 1893425
[TBL] [Abstract][Full Text] [Related]
11. Overstaging of transitional cell carcinoma: clinical significance of lamina propria fat within the urinary bladder.
Bochner BH; Nichols PW; Skinner DG
Urology; 1995 Mar; 45(3):528-31. PubMed ID: 7879346
[TBL] [Abstract][Full Text] [Related]
12. [Expression of the blood group antigens A and B in carcinoma of the urinary bladder].
Tichý M; Jansa P; Student V; Tichá V; Vanák J
Bratisl Lek Listy; 1992 Aug; 93(8):415-20. PubMed ID: 1464022
[TBL] [Abstract][Full Text] [Related]
13. Detection of circulating tumour cells in peripheral blood of patients with advanced non-metastatic bladder cancer.
Rink M; Chun FK; Minner S; Friedrich M; Mauermann O; Heinzer H; Huland H; Fisch M; Pantel K; Riethdorf S
BJU Int; 2011 May; 107(10):1668-75. PubMed ID: 20735381
[TBL] [Abstract][Full Text] [Related]
14. Words of wisdom. Re: Impact of ABO blood type on outcomes in patients with primary nonmuscle invasive bladder cancer.
Ohno Y
Eur Urol; 2014 Aug; 66(2):391. PubMed ID: 25305789
[No Abstract] [Full Text] [Related]
15. [Immunofluorescence study of the distribution of ABH cell surface antigens in bladder tumours (author's transl)].
Vallancien G; Rouger P; Leclerc JP; Kuss R
Sem Hop; 1982 May; 58(19):1161-4. PubMed ID: 6285497
[TBL] [Abstract][Full Text] [Related]
16. Correlation of urine cytology with ABO(H) antigenicity in transitional cell carcinoma of the bladder.
Das G; Glashan RW
J Clin Pathol; 1988 May; 41(5):538-9. PubMed ID: 3384984
[TBL] [Abstract][Full Text] [Related]
17. Pretreatment staging of invasive transitional cell carcinoma of the bladder. American College of Radiology. ACR Appropriateness Criteria.
Bigongiari LR; Amis ES; Bluth EI; Bush WH; Choyke PL; Fritzsche P; Holder L; Newhouse JH; Sandler CM; Segal AJ; Resnick MI; Rutsky EA
Radiology; 2000 Jun; 215 Suppl():697-702. PubMed ID: 11037487
[No Abstract] [Full Text] [Related]
18. Molecular staging of bladder cancer with RT-PCR assay for CK20 in peripheral blood, bone marrow and lymph nodes: comparison with standard histological staging.
Ribal MJ; Mengual L; Marín M; Algaba F; Ars E; Fernández PL; Oliva R; Villavicencio H; Alcaraz A
Anticancer Res; 2006; 26(1A):411-9. PubMed ID: 16475726
[TBL] [Abstract][Full Text] [Related]
19. Serum tumor markers may predict overall and disease specific survival in patients with clinically organ confined invasive bladder cancer.
Margel D; Tal R; Baniel J
J Urol; 2007 Dec; 178(6):2297-300; discussion 2300-1. PubMed ID: 17936837
[TBL] [Abstract][Full Text] [Related]
20. [The study of relationship between nuclear metrix protein 22 urinary level and the grade and stage of bladder transitional cell carcinoma].
Xin DQ; You R; Ding Y; Liu LQ; Na YQ
Zhonghua Wai Ke Za Zhi; 2006 May; 44(10):681-3. PubMed ID: 16784679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
